Browsing Tag

Новини diabetes

New drug slows progression of type I diabetes

Teplizumab was approved late last year due to impressive results in slowing the progression of type 1 diabetes in children and adolescents. Now, the researchers present new data on the effectiveness of teplizumab, which can be used in the…

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More